Marshall Wace North America’s West Pharmaceutical WST Stock Holding History

Marshall Wace North America’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$6.29M	Buy	14,806 +13,353	+919%	+$5.63M	0.03%	452
2021 Q2	$522K	Buy	+1,453	New	+$480K	﹤0.01%	1166
2020 Q1	–	Sell	-1,678	Closed	-$252K	–	1641
2019 Q4	$252K	Sell	1,678 -4,593	-73%	-$669K	﹤0.01%	925
2019 Q3	$889K	Buy	+6,271	New	+$863K	0.01%	718
2019 Q1	–	Sell	-7,584	Closed	-$743K	–	1949
2018 Q4	$743K	Buy	+7,584	New	+$823K	0.01%	682
2018 Q3	–	Sell	-24,201	Closed	-$2.4M	–	1413
2018 Q2	$2.4M	Buy	24,201 +6,564	+37%	+$604K	0.01%	721
2018 Q1	$1.56M	Buy	+17,637	New	+$1.65M	0.01%	878
2017 Q4	–	Sell	-50,240	Closed	-$4.82M	–	1639
2017 Q3	$4.82M	Sell	50,240 -95,320	-65%	-$8.62M	0.03%	558
2017 Q2	$13.8M	Buy	145,560 +21,369	+17%	+$1.97M	0.1%	249
2017 Q1	$10.2M	Buy	+124,191	New	+$10.4M	0.08%	264

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace North America's WST Position: Q3 2021 in Review

Marshall Wace North America increased its West Pharmaceutical (WST) stake by 919% in Q3 2021, buying an estimated $5.63M and bringing the position to 14,806 shares worth $6.29M. The position accounts for 0.03% of the portfolio, ranked #452.

Marshall Wace North America first reported a position in WST in Q1 2017 and has held it in 10 quarters since. The position peaked at $13.8M in Q2 2017. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

Marshall Wace North America held 14,806 shares of West Pharmaceutical worth $6.29M as of Q3 2021.
Marshall Wace North America bought 13,353 West Pharmaceutical shares in Q3 2021, an estimated $5.63M.
West Pharmaceutical made up 0.03% of Marshall Wace North America's portfolio in Q3 2021, its #452 holding.
Marshall Wace North America first reported a position in West Pharmaceutical in Q1 2017 and has held it in 10 quarters since.
Marshall Wace North America's West Pharmaceutical position peaked at $13.8M in Q2 2017.
670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.